methylprednisolone hemisuccinate has been researched along with alprostadil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Akpolat, N; Alpay, HC; Gök, U; Kabakuş, N; Kilic, A; Yilmaz, B; Yoldaş, T | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and alprostadil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Comparisons of steroid, acyclovir, lipoprostoglandin E1 and steroid + acyclovir treatments in facial paralysis: a rat study.
Topics: Acyclovir; Alprostadil; Analysis of Variance; Animals; Anti-Inflammatory Agents; Bell Palsy; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Electrophysiology; Facial Nerve; Facial Paralysis; Female; Herpesvirus 1, Human; Incidence; Injections, Intramuscular; Injections, Intraperitoneal; Methylprednisolone Hemisuccinate; Prognosis; Rats; Treatment Outcome; Vasodilator Agents | 2005 |